Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
01/2007
01/03/2007EP1739076A1 Novel BIS para-phenylenediamines joined by a linker arm substituted with one or more carboxylic radicals and/or derivatives and use in dyeing
01/03/2007EP1738824A1 Lewis-acid metal catalyst enclosed in polymer
01/03/2007EP1737831A1 Neurologically-active compounds
01/03/2007EP1737812A1 Methods of amination
01/03/2007EP1737811A1 Cetp inhibitors
01/03/2007EP1419008B1 Process for performing an imino-ene reaction
01/03/2007EP1231914B1 Nordihydroguaiaretic derivatives for use in treatment of tumors
01/03/2007CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases
01/03/2007CN1887858A Nateglinide preparing process
01/03/2007CN1887857A Prepn of DL-alanine
01/03/2007CN1887847A Substituted p-trifluoromethyl phenyl ether compound and its prepn and application
01/03/2007CN1887828A Synthesis process of 18F lebeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
01/03/2007CN1293042C Aromatic amino acid derivates and medicinal compositions
01/03/2007CN1293041C Preparation of D-(-)-1-benzene amino acetic acid
01/03/2007CN1293040C Process for the preparation of phenylalanine enamide derivatives
01/02/2007US7157596 Inhibitors of serine protease activity of matriptase or MTSP1
01/02/2007US7157594 2-Amino-3-alkoxy-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; effective for treating and preventing psychiatric disorders such as schizophrenia, anxiety, bipolar disorder and epilepsy, neurological diseases such as drug dependence, Alzheimer's disease, Huntington's chorea
12/2006
12/28/2006WO2006136564A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
12/28/2006WO2006136101A1 Glucagon like peptide-1 receptor (glp-1r) regulators, preparation methods and uses
12/28/2006WO2006009902A3 Non-natural amino acids
12/28/2006US20060293229 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
12/28/2006DE102005028500A1 Aminocarbonsäureester mit EO/PO/BuO-Blockpolymersisaten und deren Verwendung als Emulsionsspalter Amino carboxylic esters with EO / PO / BuO Blockpolymersisaten and their use as demulsifiers
12/27/2006EP1736486A1 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
12/27/2006EP1735271A2 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex
12/27/2006EP1735269A1 Process for the preparation of enantiomerically enriched beta amino acid derivatives
12/27/2006EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
12/27/2006EP1313695B1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/27/2006CN1886363A Amino acids with affinity for the alpha2delta-protein
12/27/2006CN1886362A Preparation and use of alkylating agents
12/26/2006US7154002 Phenylglycinamide derivatives containing a substituent capable of complexing with a protein metal ion, particularly an acrylhydroxamic group, e.g., 3-(3-{Benzylcarbamoyl-[formyl-(4-phenoxy-phenyl)-amino]-methyl}-phenyl)-N-hydroxy-acrylamide; antiproliferative agents
12/26/2006US7153997 N-hydroxyphenoxyphenyl derivatives of glycine or valine, e.g., N-[3,5-Dichloro-4-(4-hydroxy-3-isopropyl-5-methylphenoxy)benzoyl]glycine; treating metabolic disorders or diseases dependent upon the expression of a T3 regulated gene
12/26/2006US7153869 Substituted amino acids as erythropoietin mimetics
12/21/2006WO2006110783A3 Process for making (s)-pregabalin
12/21/2006US20060287550 Such as 2-dimethylaminoethyl (meth)acrylate from transesterification of methyl or ethyl (meth)acrylate with 2-dimethylaminoethanol in the presence of a catalyst and polymerization inhibitor, followed by slight dilution and distillation; polymer flocculants; improved by-product inhibition
12/21/2006US20060287542 Non-ionic surfactants for solubilizing poorly solubule molecules
12/21/2006US20060287392 Gabapentin compositions
12/21/2006US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/20/2006EP1734034A2 Carboxylic acid salts of beta-alanine esters or -amides
12/20/2006EP1734033A1 Method of purifying amino acid
12/20/2006EP1732879A1 Processes for the preparation of iodinated amino-aryl compounds
12/20/2006EP1732865A1 Fluoridation method
12/20/2006EP1468004B1 Metal complexes for use in metathesis
12/20/2006EP1360002B1 Improved metal-ligand complex catalyzed processes
12/20/2006CN1882607A Method for synthesis of perindopril and its pharmaceutically acceptable salts
12/20/2006CN1880299A Gabapentin hydrochloride and its intermediate preparation method
12/20/2006CN1290822C Process for preparing gabapentin
12/20/2006CN1290821C Propionyl-L-carnitine synthesis technology
12/20/2006CN1290820C Preparation method of aluminium zirconium glycinate as antiperspirant
12/20/2006CN1290485C Compounds for a controlled release of active molecules
12/19/2006US7151193 Process for the preparation of pure gabapentin “Form II”
12/19/2006US7151191 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery
12/14/2006WO2006133346A2 Ferric and acid complex
12/14/2006WO2006132442A1 Vitamin d-like compound
12/14/2006US20060281945 Method of making a dil-lysine monosulfate trihydrate crystal
12/14/2006US20060281926 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/14/2006US20060281816 Pregabalin free of lactam and a process for preparation thereof
12/14/2006US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/14/2006CA2610867A1 Ferric and acid complex
12/13/2006EP1731500A1 5-aminolevulinic acid salt, process for producing the same and use thereof
12/13/2006EP1730099A2 Mitotic kinesin inhibitors
12/13/2006EP1663949A4 Method for the manufacture of l-threonine-o-(1,1-dimethylethyl)-1,1-dimethylethyl ester
12/13/2006EP0738260B2 Pesticides
12/13/2006CN1878765A Synthesis of quinoline 5-carboxamides useful for the preparation of PDE IV inhibitors
12/13/2006CN1878748A Process of hydrocyanation of unsaturated carboxylic acid derivatives
12/13/2006CN1878616A Use of a derivative of aspartic acid as a collector in froth flotation processes
12/13/2006CN1289549C High molecular weight polymers containing pendant salicylic acid groups
12/13/2006CN1289467C Dibenzylamine compound and medicinal use thereof
12/13/2006CN1289466C Pharmaceutical compounds
12/13/2006CN1289460C Aryl-acrylic acid esters
12/12/2006US7148378 Analgesics; neuropathic pain; bipolar disorders
12/12/2006US7148377 4-Alkoxy cyclohexane-1-amino-carboxylic acid esters and method for the production thereof
12/12/2006US7148376 Crystal structures of (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-Phenylalanine and solvates used as hypoglycemic agents
12/12/2006US7148372 1,1-bis(alkoxycarbonyl)-omega-tert-amino branched chain alkenes or conjugated polyenes; especially for the synthesis of retinoic acid, vitamin A (retinol), retinal, retinonitrile and etretinate
12/12/2006US7148371 Method for producing lysine derivative
12/07/2006WO2006129781A1 Process for production of dibenzoxepin derivative
12/07/2006WO2006128706A1 Biosynthetic production of (5s,6s)-6-amino-5-hydroxycyclohexa-1,3-diene-1-carboxylic acid (2,3-cha)
12/07/2006US20060276674 Method for purifying succinic acid from fermentation broth
12/07/2006US20060276673 Process for producing amino acid derivatives
12/07/2006US20060276659 Process for preparation of perindopril and salts thereof
12/07/2006US20060276544 Containing 0.15-0.03% isobutylglutarric acid
12/07/2006US20060276543 Characterized by X-ray powder diffraction peaks at about 5.8, 18.4, 19.2, 20.7, and 23.7 degrees 2 theta +-0.2 degrees 2 theta, comprising crystallizing the pregabalin from a mixture of acetonitrile and an alcohol; use as pharmaceutical dosage form of drug with targeted release profile
12/07/2006DE102005025283A1 Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin Stable ingredient complex salts of O-acetylsalicylic acid with basic amino acids and glycine
12/06/2006EP1728872A1 Biosynthetic production of (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-diene-1-carboxylic acid (2,3-CHA)
12/06/2006EP1728782A2 Monomers and network polymers obtained therefrom
12/06/2006EP1727786A1 Acid addition salts of 5-aminolevulinic acid or its derivatives
12/06/2006EP1727785A1 Phenyl indan derivatives
12/06/2006EP1727620A1 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
12/06/2006CN1874991A Compound capable of binding S1P receptor and pharmaceutical use thereof
12/05/2006USRE39419 Estrogen agonist/antagonist metabolites
12/05/2006US7145040 Process for the preparation of amino acids useful in the preparation of peptide receptor modulators
12/05/2006US7145039 Transfection reagents
12/05/2006US7145030 Reacting sulfonylated beta-hydroxycarboxylic acid compounds with aromatic amines; reduction catalysts; for production of drugs and agrochemicals
11/2006
11/30/2006WO2006126825A1 Composition comprising tetrafluorobenzyl derivatives or salts of thereof for injection
11/30/2006WO2006125397A1 Nonsteroic androgen acceptor regulators, preparation process, pharmaceutical composition and use thereof
11/30/2006US20060270871 Polymorphic form i of pregabalin and processes for its preparation
11/29/2006EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006EP1725519A1 Amino acid derivatives
11/29/2006EP1409448B1 Process for the preparation of (r)- or (s)-aminocarnitine inner salt, the salts and derivatives thereof
11/29/2006EP1187805B1 Process for preparing r-(-)-carnitine from s-(-)-chlorosuccinic acid or from a derivative thereof
11/29/2006CN1871204A Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl-pyrazole-4-carboxylic acid esters
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 215